Page last updated: 2024-10-29

ifosfamide and Left Ventricular Dysfunction

ifosfamide has been researched along with Left Ventricular Dysfunction in 1 studies

Research Excerpts

ExcerptRelevanceReference
" The patients were treated between 1/1/1998 and 6/30/1999 according to the sarcoma protocols COSS-96, CWS-96, and EICESS-92, the median cumulative doses of the focussed drugs were for cisplatin: 360 mg/m(2), for doxorubicin: 270 mg/m(2), and for ifosfamide: 24 g/m(2)."5.11Late effects surveillance system for sarcoma patients. ( Beck, JD; Bielack, S; Langer, T; Paulussen, M; Stöhr, W; Treuner, J, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Langer, T1
Stöhr, W1
Bielack, S1
Paulussen, M1
Treuner, J1
Beck, JD1

Trials

1 trial available for ifosfamide and Left Ventricular Dysfunction

ArticleYear
Late effects surveillance system for sarcoma patients.
    Pediatric blood & cancer, 2004, Volume: 42, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Agents; Child; Child, Preschool; Cisplatin; Doxorubicin; Feasibili

2004